Trial Profile
Determining the Optimal Dose of Tranexamic Acid in Decreasing Blood Loss During Lower Extremity Total Joint Arthroplasty
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2020
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- 27 Oct 2015 New trial record